BioPharmCatalyst

BioPharmCatalyst

ACADIA Pharmaceuticals Inc. has a significant catalyst event scheduled for March 12th, 2023. After a prolonged decline, the stock has rebounded and broken out of a downward trend, indicating potential for upward movement. Investors should keep an eye on this biotech company as it approaches the catalyst date. Additional information on biotech catalysts can be...

BioPharmCatalyst

Intellia Therapeutics Inc. NASDAQ: NTLA Chart Overview 03/28/22 Intellia is trading in a 9-month downward channel pullback, closing the gap created by the release of Phase 1 data of NTLA-2001 to treat ATTR. The release caused a bull pennant that led to a reversal into a downward channel. We are tracking support at $56 and a resistance line is at $90. The...

BioPharmCatalyst

BriaCell Therapeutics Corp. NASDAQ: BCTX Chart Overview 03/28/22 BriaCell broke out of a 3-month downward channel into an upward channel. We are tracking support lines at $4.20, $5, and $5.89, and resistance lines at $9.60 and $10.47. Friday and today shares are trading overextended and coming up to resistance both in terms of channel lines, candlesticks,...